Journal Information
Statistics
Follow this link to access the full text of the article
Original Article
Value of the 18F-choline PET/MR hybrid technique on the therapeutic approach in patients with prostate cancer treated with prostatectomy and elevation of prostate specific antigen levels less than 1ng/ml
Impacto de la tecnología híbrida PET/RM con 18F-colina en la estrategia terapéutica de los pacientes con cáncer de próstata tratados con prostatectomía que presentan elevación del antígeno prostático específico inferior a 1ng/ml
J.R. García
, A. Compte, M. Buxeda, S. Mourelo, M. Soler, A. Blanch, E. Valls, E. Riera
Corresponding author
CETIR, ASCIRES, Barcelona, Spain